Atlas Trials

RANKL Inhibition and Breast Tissue Biomarkers

Clinical trial NCT03629717 · COMPLETED

Trial details

NCT number
NCT03629717
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Breast Cancer PreventionMammographic Density
Start date
2018-06-01
Primary completion
2018-12-03
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.